U.S. Markets closed

Novartis’s Alcon faces Chinese corruption allegations, FT reports

Novartis eye care unit Alcon said it would investigate claims it used fake clinical trials to bribe doctors in China, the latest in what has become a steady stream of corruption allegations against mostly foreign pharmaceutical groups in the country, reports the Financial Times.